Skip to main content
Louis Falo, MD, Dermatology, Pittsburgh, PA

LouisDFaloMDPhD

Dermatology Pittsburgh, PA

Professor and Chairman

Dr. Falo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Falo's full profile

Already have an account?

  • Office

    3601 5th Ave
    Ste 5A
    Pittsburgh, PA 15213
    Phone+1 412-648-3263

Education & Training

  • Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's Hosp
    Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1989 - 1992
  • Massachusetts General Hospital
    Massachusetts General HospitalInternship, Internal Medicine, 1988 - 1989
  • Harvard Medical School
    Harvard Medical SchoolClass of 1988

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1993 - 2024

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2003

Publications & Presentations

PubMed

Journal Articles

  • A Microarray Patch SARS-CoV-2 Vaccine Induces Sustained Antibody Responses and Polyfunctional Cellular Immunity  
    Stephen C. Balmert Zohreh Gholizadeh Ghozloujeh Cara Donahue Carey Li’an H. Williams Jiying Zhang Preeti Shahi Maher Amer Tina L. Sumpter Geza Erdos Emrullah Korkmaz L..., iScience
  • Tumor-Derived High-Mobility Group Box 1 and Thymic Stromal Lymphopoietin Are Involved in Modulating Dendritic Cells to Activate T Regulatory Cells in a Mouse Model  
    Louis Falo, MD, Cancer Immunology, Immunotherapy

Press Mentions

  • Oxford University Has a Shot at Vaccine Billions. Or Does It?
    Oxford University Has a Shot at Vaccine Billions. Or Does It?September 23rd, 2020
  • US Companies Seek to Make History as Testing for COVID-19 Vaccines Begins
    US Companies Seek to Make History as Testing for COVID-19 Vaccines BeginsJune 23rd, 2020
  • Tackling the Novel Coronavirus Calls for Novel Ideas
    Tackling the Novel Coronavirus Calls for Novel IdeasMay 6th, 2020
  • Join now to see all